Form 4: ANI Pharmaceuticals SVP & CFO Stephen Carey Reports Changes in Beneficial Ownership

Stephen Carey, SVP & CFO of ANI Pharmaceuticals, reports acquisition and disposal of common stock and derivative securities.

Summary

• Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership.
• On February 12, 2025, Carey acquired 24,808 shares of common stock through a restricted stock award that vests in four equal annual installments.
• On the same date, Carey also acquired 16,538 shares of common stock representing performance stock units that vest based on performance targets.
• On February 14, 2025, 1,730 shares were disposed of at $58.92 per share for tax purposes related to the vesting of 5,368 shares of restricted stock.
• Following these transactions, Carey beneficially owns 194,084 shares of ANI Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the holdings and transactions of key executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.

Key Dates

Keywords

Form 4, Beneficial Ownership, ANI Pharmaceuticals, Stephen Carey, ANIP, Stock Options, Restricted Stock, Performance Stock Units